No long-term cognitive effects of mHT were seen in the KEEPS Continuation study, about 10 years after completion of randomized treatment ...

Vutrisiran, a transthyretin-directed small interfering RNA therapeutic, is currently approved under the brand name Amvuttra ® for the treatment of polyneuropathy manifestations of hereditary ...

The researchers used the Baltimore Longitudinal Study of Aging, a prospective cohort study of community-dwelling older adults.

Imkeldi is a liquid formulation of imatinib that utilizes proprietary technology to allow for accurate dosing and an alternative formulation to tablets.

The researchers found that postpartum depression prevalence doubled during the study period, increasing from 9.4% in 2010 to 19.0% in 2021. (HealthDay News) — Diagnosis of postpartum depression ...

(HealthDay News) — More than half of all U.S. adults are eligible for semaglutide therapy, according to a research letter published online Nov. 18 in JAMA Cardiology to coincide with the American ...

Credit: Endo, Inc At this time, there have been no reports of adverse events related to this recall. While the blister strips ...

G400 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset G4000 Localization-related (focal) (partial) idiopathic epilepsy and ...

F19122 Other psychoactive substance abuse with intoxication with perceptual disturbances F19129 Other psychoactive substance abuse with intoxication, unspecified F1913 Other psychoactive substance ...

To start patients on Miplyffa, prescribers can fill out an enrollment form on Miplyffa.com. Miplyffa™ (arimoclomol) is now available for use in combination with miglustat for the treatment of ...

The researchers found that compared with natural infection, maternal RSV vaccination resulted in significantly higher maternal and cord anti-RSV F antibody levels. (HealthDay News) — Respiratory ...

The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database. The Food and Drug Administration (FDA) has approved ...